Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-K, Date: 2014-12-09, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: TPI/20141209/10-K/1/000.htm SEC Original: f10k2014_tianyinpharma.htm
TIANYIN PHARMACEUTICAL CO., INC FORM 10-K INDEX Page PART I Item 1 Description of Business 3 Item 1A Risk Factors 14 Item 1B Unresolved Staff Comments 25 Item 2 Description of Property 26 Item 3 Legal Proceedings 26 Item 4 Removed and Reserved 26 PART II Item 5 Market for Common Equity and Related Stockholder Matters and Issuer Purchases of

---

---

Webplus: TPI/20141209/10-K/2_EX-31.1/000.htm SEC Original: f10k2014ex31i_tianyinpharma.htm
CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the

---

---

Webplus: TPI/20141209/10-K/3_EX-31.2/000.htm SEC Original: f10k2014ex31ii_tianyinpharma.htm
CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James J. Tong, certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: TPI/20141209/10-K/4_EX-32.1/000.htm SEC Original: f10k2014ex32i_tianyinpharma.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer EX-32.1 4 f10k2014ex32i_tianyinpharma.htm CERTIFICATION

---

---

Webplus: TPI/20141209/10-K/5_EX-32.2/000.htm SEC Original: f10k2014ex32ii_tianyinpharma.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James J. Tong Chief Financial Officer EX-32.2 5 f10k2014ex32ii_tianyinpharma.htm CERTIFICATION

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 10-K, Date: 2014-12-09, XBRL Interactive FinancialsCIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041